← Back to Search

Other

Topical Latanoprost/Minoxidil formulation for Alopecia Areata

Q: Are octogenarians admissible to this experimental research?

The requisite age for this trial is 22 to 65 years old. There are separate trials available for those younger or older than the specified parameters.

Q: Am I eligible to register for this research project?

This medical trial is accepting 12 candidates that have <a href="https://www.withpower.com/clinical-trials/alopecia-areata">alopecia areata</a> and fall in the age range of 22 to 65 years old.

Q: Is this medical experiment still open to new participants?

This clinical trial, which was first made public on March 11th 2023, is currently recruiting patients. The latest update to the listing occurred on March 17th 2023 according to information found on clinicaltrials.gov.

Q: What is the upper limit for participants enrolled in this research endeavor?

Affirmative. Clinicaltrials.gov records demonstrate that the search for participants is fully underway; it started on March 11th of 2023 and was most recently updated on the 17th of this same month. This research seeks to enroll 12 individuals over one site.

Phase < 1

Recruiting

Led By Dan Cosgrove, M.D.

Research Sponsored by Aneira Pharma, Inc.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 90 days

Awards & highlights

Study Summary

This trial is testing a new combination treatment to see if it can safely help people with thinning eyebrows.

Eligible Conditions

Alopecia Areata

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 90 days

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~90 days

This trial's timeline: 3 weeks for screening, Varies for treatment, and 90 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Target Area Hair Count

Secondary outcome measures

Change in Total Area Hair Darkness

Standardized Global Photographs

Other outcome measures

Subject Self Assessment

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: Topical Latanoprost/Minoxidil formulationExperimental Treatment1 Intervention

8 participants: Topical Latanoprost/Minoxidil formulation applied to both eyebrows once a day for 90 days

Group II: Control GroupPlacebo Group1 Intervention

4 participants: Vehicle applied to both eyebrows once a day for 90 days

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Aneira Pharma, Inc.Lead Sponsor

1 Previous Clinical Trials

14 Total Patients Enrolled

1 Trials studying Alopecia Areata

14 Patients Enrolled for Alopecia Areata

Dan Cosgrove, M.D.Principal InvestigatorWellMax

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are octogenarians admissible to this experimental research?

"The requisite age for this trial is 22 to 65 years old. There are separate trials available for those younger or older than the specified parameters."

Answered by AI

Am I eligible to register for this research project?

"This medical trial is accepting 12 candidates that have alopecia areata and fall in the age range of 22 to 65 years old."

Answered by AI

Is this medical experiment still open to new participants?

"This clinical trial, which was first made public on March 11th 2023, is currently recruiting patients. The latest update to the listing occurred on March 17th 2023 according to information found on clinicaltrials.gov."

Answered by AI

What is the upper limit for participants enrolled in this research endeavor?

"Affirmative. Clinicaltrials.gov records demonstrate that the search for participants is fully underway; it started on March 11th of 2023 and was most recently updated on the 17th of this same month. This research seeks to enroll 12 individuals over one site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Proof of Concept Study of Latanoprost/Minoxidil (ANR-001.1) Topical Formulation

2023. "Proof of Concept Study of Latanoprost/Minoxidil (ANR-001.1) Topical Formulation". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05790941.